Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations
Amanda McCleery, Keith H. Nuechterlein
Dialogues in Clinical Neuroscience (2019) Vol. 21, Iss. 3, pp. 239-248
Open Access | Times Cited: 182

Showing 1-25 of 182 citing articles:

Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies
Nina Dedic, Heather Dworak, Courtney Zeni, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13185-13185
Open Access | Times Cited: 78
Microglia and cognitive impairment in schizophrenia: translating scientific progress into novel therapeutic interventions
Chuanjun Zhuo, Hongjun Tian, Xueqin Song, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia
Eric D. Achtyes, Seth C. Hopkins, Nina Dedic, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1543-1556
Open Access | Times Cited: 31
Integrating Clinical Neuropsychology and Psychotic Spectrum Disorders: A Systematic Analysis of Cognitive Dynamics, Interventions, and Underlying Mechanisms
Evgenia Gkintoni, Μαρία Σκώκου, Philippos Gourzis
Medicina (2024) Vol. 60, Iss. 4, pp. 645-645
Open Access | Times Cited: 15
Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review
Abigail Gee, Paola Dazzan, Anthony A. Grace, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Inflammation and cognition in severe mental illness: patterns of covariation and subgroups
Linn Sofie Sæther, Thor Ueland, Beathe Haatveit, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 3, pp. 1284-1292
Open Access | Times Cited: 32
Combining transcranial magnetic stimulation with training to improve social cognition impairment in schizophrenia: a pilot randomized controlled trial
Alessandra Vergallito, Bianca Gramano, Kevin La Monica, et al.
Frontiers in Psychology (2024) Vol. 15
Open Access | Times Cited: 6
Conceptualization and characterization of “primary” and “secondary” cognitive impairment in schizophrenia
Antonio Vita, Gabriele Nibbio, Sergio Barlati
Psychiatry Research (2024) Vol. 340, pp. 116126-116126
Open Access | Times Cited: 6
Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial
F. Markus Leweke, Cathrin Rohleder, C.W. Gerth, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 36
Remote cognitive assessment in severe mental illness: a scoping review
Katie M. Lavigne, Geneviève Sauvé, Delphine Raucher‐Chéné, et al.
Schizophrenia (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 24
Neurocognitive Deficits in First-Episode and Chronic Psychotic Disorders: A Systematic Review from 2009 to 2022
Nadja Tschentscher, Christian Franz Josef Woll, Julia C. Tafelmaier, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 299-299
Open Access | Times Cited: 14
Using virtual reality to improve verbal episodic memory in schizophrenia: A proof-of-concept trial
Bryce J. M. Bogie, Chelsea Noël, Feng Long Gu, et al.
Schizophrenia Research Cognition (2024) Vol. 36, pp. 100305-100305
Open Access | Times Cited: 5
Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes
HuiRu Cui, Anthony J. Giuliano, Tianhong Zhang, et al.
Schizophrenia Research (2020) Vol. 226, pp. 138-146
Closed Access | Times Cited: 34
Feasibility and Efficacy of Virtual Reality Interventions to Improve Psychosocial Functioning in Psychosis: Systematic Review
Alexandra Schroeder, Bryce J. M. Bogie, Tabassum T Rahman, et al.
JMIR Mental Health (2021) Vol. 9, Iss. 2, pp. e28502-e28502
Open Access | Times Cited: 32
Much of the Neurocognitive Impairment in Schizophrenia is Due to Factors Other Than Schizophrenia Itself: Implications for Research and Treatment
Steffen Moritz, Steven M. Silverstein, Thomas Beblo, et al.
Schizophrenia Bulletin Open (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 28
Association between lipid metabolism and cognitive function in patients with schizophrenia
Huamin Liu, Zhiwei Huang, Xiaochun Zhang, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 20
Measuring Cognitive Impairments Associated With Schizophrenia in Clinical Practice: Overview of Current Challenges and Future Opportunities
Keith H. Nuechterlein, Henry A. Nasrallah, Dawn I. Velligan
Schizophrenia Bulletin (2024)
Open Access | Times Cited: 4
Treatment of Cognitive Impairment Associated with Schizophrenia Spectrum Disorders: New Evidence, Challenges, and Future Perspectives
Irene Calzavara‐Pinton, Gabriele Nibbio, Sergio Barlati, et al.
Brain Sciences (2024) Vol. 14, Iss. 8, pp. 791-791
Open Access | Times Cited: 4
Schizophrenia: Antipsychotics and drug development
Gary Remington, Margaret Hahn, Sri Mahavir Agarwal, et al.
Behavioural Brain Research (2021) Vol. 414, pp. 113507-113507
Closed Access | Times Cited: 25
Negative mood states as a correlate of cognitive performance and self-assessment of cognitive performance in bipolar disorder versus schizophrenia
Nina Dalkner, Raeanne C. Moore, Colin A. Depp, et al.
Schizophrenia Research (2023) Vol. 252, pp. 1-9
Open Access | Times Cited: 10
Efficacy of brain stimulation therapies across psychiatric, movement, and cognitive disorders: an umbrella review synthesizing meta-analyses of randomized controlled trials
Zhenyue Zu, Fenglan Chen, Linxi Yang, et al.
EClinicalMedicine (2025) Vol. 80, pp. 103046-103046
Closed Access
Deviant sound frequency and time stimuli in auditory oddball tasks reveal persistent aberrant brain activity in patients with psychosis and symptomatic remission.
J. Goena Vives, Cristina Vidal-Adroher, Sergio M. Solís‐Barquero, et al.
Journal of Psychiatric Research (2025)
Closed Access
Specific immune-inflammatory profiles and neurocognitive deficits predict illness trajectories in people with type 2 diabetes mellitus or psychiatric disorders
Joan Vicent Sánchez‐Ortí, Patricia Correa‐Ghisays, Vicent Balanzá‐Martínez, et al.
Brain Behavior & Immunity - Health (2025) Vol. 44, pp. 100962-100962
Open Access
The awareness, characterization, and burden of Cognitive Impairment Associated with Schizophrenia (CIAS) in clinical practice: Results from a nationwide survey in Italy
Antonio Vita, Sergio Barlati, Roberto Cavallaro, et al.
Schizophrenia Research Cognition (2025) Vol. 40, pp. 100352-100352
Closed Access
Proposal for a Novel Classification of Patients With Enlarged Ventricles and Cognitive Impairment Based on Data‐Driven Analysis of Neuroimaging Results in Patients With Psychiatric Disorders
Yuka Yasuda, Satsuki Ito, Junya Matsumoto, et al.
Neuropsychopharmacology Reports (2025) Vol. 45, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top